1. 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. (2nd January 2020) Authors: Musella, Alessandra; Fresegna, Diego; Rizzo, Francesca Romana; Gentile, Antonietta; De Vito, Francesca; Caioli, Silvia; Guadalupi, Livia; Bruno, Antonio; Dolcetti, Ettore; Buttari, Fabio; Bullitta, Silvia; Vanni, Valentina; Centonze, Diego; Mandolesi, Georgia Journal: Expert opinion on therapeutic targets Issue: Volume 24:Number 1(2020:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. (off)Targeting UPR signaling: the race toward intervening ER proteostasis. (1st February 2018) Authors: Pérez-Arancibia, Rodrigo; Rivas, Alexis; Hetz, Claudio Journal: Expert opinion on therapeutic targets Issue: Volume 22:Number 2(2018:Feb.) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. (June 2013) Authors: Olanich, Mary E; Barr, Frederic G Journal: Expert opinion on therapeutic targets Issue: Volume 17:Number 5(2013:May) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A key opinion leader interview with Prof D Santini: insight into cancer research. (March 2015) Authors: Palmer, Claudia; Santini, Daniele Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 3(2015:Mar.) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A preclinical overview of emerging therapeutic targets for glomerular diseases. (3rd July 2019) Authors: Cassis, Paola; Zoja, Carlamaria; Perico, Luca; Remuzzi, Giuseppe Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 7(2019:Jul.) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A short commentary on the review by Weller and Kuchta: the DNA helicase–primase complex as a target for herpes virus infection. (October 2013) Authors: Field, Hugh J Journal: Expert opinion on therapeutic targets Issue: Volume 17:Number 10(2013:Oct.) Page Start: 1113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH). (3rd October 2021) Authors: Roberts, Stuart K; Majeed, Ammar Journal: Expert opinion on therapeutic targets Issue: Volume 25:Number 10(2021) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A vasculature-centric approach to developing novel treatment options for glioblastoma. (1st February 2021) Authors: Wirsching, Hans-Georg; Roth, Patrick; Weller, Michael Journal: Expert opinion on therapeutic targets Issue: Volume 25:Number 2(2021) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ABCG2 as a therapeutic target candidate for gout. (1st February 2018) Authors: Fujita, Kyoko; Ichida, Kimiyoshi Journal: Expert opinion on therapeutic targets Issue: Volume 22:Number 2(2018:Feb.) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Aberrant lipid metabolism as a therapeutic target in liver cancer. (3rd June 2019) Authors: Pope, Evans D.; Kimbrough, Erinmarie O.; Vemireddy, Lalitha Padmanabha; Surapaneni, Phani Keerthi; Copland, John A.; Mody, Kabir Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 6(2019:Jun.) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗